Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 143K 124K 114K 107K 201K 13.56M 203K 1.34M 524K 6.64M 538K 527K 23.01M | P/E Ratio 2022 |
-0.81x | P/E Ratio 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 19.78M 18.21M 17.1M 32.1M 2.17B 32.44M 215M 83.83M 1.06B 86.12M 84.29M 3.68B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | -3.88% | +17.24% | -11.61% | 176B | |
| +0.32% | -1.97% | -19.43% | +26.97% | 148B | |
| +0.40% | -3.30% | -9.41% | -24.65% | 128B | |
| -0.10% | -4.48% | -53.92% | -13.91% | 69.5B | |
| +3.03% | +1.93% | +19.26% | -2.95% | 49.68B | |
| +0.97% | +0.60% | -23.33% | -33.14% | 45.26B | |
| -0.85% | -4.43% | +8.79% | +6.89% | 36.88B | |
| +1.93% | -1.60% | +5.00% | +35.67% | 35.13B | |
| -1.44% | -3.35% | -12.43% | -18.88% | 29.46B | |
| Average | +0.51% | -0.91% | -7.58% | -3.96% | 79.74B | |
| Weighted average by Cap. | +0.43% | -0.65% | -6.62% | -4.02% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.49M 1.37M 1.29M 2.42M 164M 2.44M 16.22M 6.32M 80.07M 6.49M 6.35M 277M | 1.98M 1.7M 1.57M 1.47M 2.77M 187M 2.8M 18.55M 7.23M 91.57M 7.42M 7.26M 317M |
| Net income | -16.08M -13.85M -12.76M -11.98M -22.49M -1.52B -22.73M -151M -58.73M -744M -60.33M -59.05M -2.58B | -29.31M -25.26M -23.26M -21.84M -41.01M -2.77B -41.44M -275M -107M -1.36B -110M -108M -4.7B |
| Net Debt | 20.53M 17.69M 16.29M 15.29M 28.71M 1.94B 29.02M 192M 74.98M 950M 77.03M 75.4M 3.29B | 22.8M 19.65M 18.1M 16.99M 31.9M 2.16B 32.24M 214M 83.31M 1.06B 85.58M 83.77M 3.66B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
